Pfizer says Torisel-Avastin failed in cancer study

Nancy Dell: Breast Cancer, Berries

1. After seeing the news about Angelina Jolie and breast cancer, I wonder what foods can reduce the risk?

2. I hear so much about how good blueberries are for you. What about strawberries?

Legislation to limit cancer expenses

Patients suffering from rare and chronic diseases often face …

Former Marine felt cancer a payback

Ron Poirier couldn't escape the feeling that his cancer was …

Marine base exposed to toxic tap water

A simple test could have alerted officials that the drinking …

"Bionic Hand" opens new world

Man who lost his arm to cancer can now hold his daughter.

No difference in disease progression

Updated: Friday, 10 Aug 2012, 4:37 PM EDT
Published : Friday, 10 Aug 2012, 4:37 PM EDT

The Associated Press

NEW YORK (AP) - Pfizer said Friday that its drug Torisel failed to help patients with a form of advanced kidney cancer when combined with Roche's drug Avastin.

The study compared renal cell carcinoma patients taking the Torisel-Avastin combination to those taking Avastin plus another cancer drug.

Patients taking the Pfizer combination did not show slower disease progression than those in the other group. Pfizer said.

Torisel is already approved as a stand-alone treatment for advanced renal cell carcinoma.

Pfizer says Torisel-Avastin failed in cancer study

No difference in disease progression

Site Tools